| Jasmine Gowarty, | |
|
1901 S Col Rowe Blvd, Mcallen, TX 78503-1271 | |
| (956) 687-5150 | |
| Not Available |
| Full Name | Jasmine Gowarty |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 8 Years |
| Location | 1901 S Col Rowe Blvd, Mcallen, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003263732 | NPI | - | NPPES |
| 651460 | Other | TX | PHYSICIAN IN TRAINING PERMIT (PIT) FROM THE TEXAS MEDICAL BOARD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rio Grande Regional Hospital | Mcallen, TX | Hospital |
| South Texas Health System | Edinburg, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oncology Pa | 5395658934 | 855 |
News Archive
An investigation into how often wheelchair users are killed in car-pedestrian crashes finds they are a third more likely to die than non-wheelchair users; more than half of those deaths occur at intersections.
Community screening for osteoporosis could prevent more than a quarter of hip fractures in older women, according to new research.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient has a specific genotype - homozygous for the arginine 389 polymorphism in the beta-1 adrenergic receptor.
The two-year study led by Dr Jackie Sanders in the School of Sociology, Social Policy and Social Work followed three groups of teenagers between the ages of 13 and 15 - those no longer in school, those at a co-educational high school performing at an average level, and those in accelerated classes at single-sex schools.
› Verified 6 days ago
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
An investigation into how often wheelchair users are killed in car-pedestrian crashes finds they are a third more likely to die than non-wheelchair users; more than half of those deaths occur at intersections.
Community screening for osteoporosis could prevent more than a quarter of hip fractures in older women, according to new research.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient has a specific genotype - homozygous for the arginine 389 polymorphism in the beta-1 adrenergic receptor.
The two-year study led by Dr Jackie Sanders in the School of Sociology, Social Policy and Social Work followed three groups of teenagers between the ages of 13 and 15 - those no longer in school, those at a co-educational high school performing at an average level, and those in accelerated classes at single-sex schools.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jasmine Gowarty, Po Box 911230, Dallas, TX 75391-1230 Ph: (972) 997-8000 | Jasmine Gowarty, 1901 S Col Rowe Blvd, Mcallen, TX 78503-1271 Ph: (956) 687-5150 |
News Archive
An investigation into how often wheelchair users are killed in car-pedestrian crashes finds they are a third more likely to die than non-wheelchair users; more than half of those deaths occur at intersections.
Community screening for osteoporosis could prevent more than a quarter of hip fractures in older women, according to new research.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient has a specific genotype - homozygous for the arginine 389 polymorphism in the beta-1 adrenergic receptor.
The two-year study led by Dr Jackie Sanders in the School of Sociology, Social Policy and Social Work followed three groups of teenagers between the ages of 13 and 15 - those no longer in school, those at a co-educational high school performing at an average level, and those in accelerated classes at single-sex schools.
› Verified 6 days ago
Dona E Cooper-dockery, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 E Nolana Ave, Ste 12, Mcallen, TX 78504 Phone: 956-686-8802 Fax: 956-686-3083 | |
Dr. Juan Jose Salazar, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 E Nolana Ave Ste 2, Mcallen, TX 78504 Phone: 956-687-1177 Fax: 956-687-3290 | |
Dr. Encarnacion Rodriguez, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4300 N Mccoll Rd, Mcallen, TX 78504 Phone: 956-630-1170 | |
Rodrigo Erana, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 Us Expressway 83, Mcallen, TX 78503 Phone: 956-661-9840 Fax: 956-661-9841 | |
Dr. Victoria A Rodriguez-quick, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 501 N Ware Rd, Mcallen, TX 78501 Phone: 956-668-0044 | |
Dr. Numan A Arafat, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 E Ridge Rd, Suite 202, Mcallen, TX 78503 Phone: 956-686-5410 |